Abstract
In a double blind randomised controlled trial, 30 infants with chronic lung disease received fluticasone propionate or placebo for one year. There were no significant differences between treatment groups in the incidence of any day or night time symptoms or any other outcome measures.
Original language | English |
---|---|
Pages (from-to) | F62-F63 |
Journal | Archives of Disease in Childhood - Fetal and Neonatal Edition |
Volume | 87 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2002 |